title: Less postnatal steroids, more bronchopulmonary dysplasia: a population-based study in very low birthweight infants.
abstract: OBJECTIVE
  To study the association between reduced use of postnatal steroids for bronchopulmonary dysplasia (BPD) in very low birthweight (VLBW) infants and oxygen (O(2))-dependency at 28 days of age and at 36 weeks postmenstrual age.
  
  
  METHODS
  Large national database study.
  
  
  METHODS
  The Israel National VLBW Neonatal Database.
  
  
  METHODS
  The sample included infants born between 1997 and 2004, of gestational age 24-32 weeks, who required mechanical ventilation or O(2) therapy. Four time periods were compared: 1997-8 (era 1, peak use), 1999-2000 (era 2, intermediate), 2001-2 (era 3, expected reduction) and 2003-4 (era 4, lowest). The outcome variable "oxygen dependency" was based on clinical criteria. Multivariate regression models were used to account for confounding variables.
  
  
  RESULTS
  Steroid use fell significantly from 23.5% in 1997-8 to 11% in 2003-4 (p<0.005). After adjustment for relevant confounding variables, the odds ratio for O(2) therapy at 28 days in era 4 versus era 1 was 1.75, 95% confidence interval (CI) 1.47 to 2.09 and 1.41, 95% CI 1.15 to 1.73 at 36 weeks postmenstrual age. The mean duration of O(2) therapy increased from 25.3 days (95% CI 23.3 to 26.3) in era 1, to 28.0 days (95% CI 26.6 to 29.4) in era 4. Survival increased from 78.5% in era 1 to 81.6% in era 4 (p<0.005).
  
  
  CONCLUSIONS
  The use of steroids has fallen considerably since the awareness of the adverse effects of this treatment. This change has been temporally associated with increased O(2) dependency at 28 days of age and at 36 weeks postmenstrual age. The prolongation of O(2) therapy was modest in degree.
authors.affiliation: Department of Neonatology, Kaplan Medical Center, Rehovot, Hadassah Medical School, Hebrew University, Jerusalem, Israel. eric_ s@clalit.org.il
authors.forename: E S
authors.initials: ES
authors.lastname: Shinwell
authors.forename: L
authors.initials: L
authors.lastname: Lerner-Geva
authors.forename: A
authors.initials: A
authors.lastname: Lusky
authors.forename: B
authors.initials: B
authors.lastname: Reichman
mesh_terms: D001997:Bronchopulmonary Dysplasia / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D005260:Female; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D019102:Infant, Very Low Birth Weight; D008297:Male; D010100:Oxygen / Q000627:therapeutic use; D011295:Prenatal Care / Q000379:methods; D011446:Prospective Studies; D013256:Steroids / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D013256:Steroids; D010100:Oxygen